Duke Clinical Research Unit

Durham, North Carolina 27710

0 studies enrolling now · 19 studies all time

What they study most

Anesthesia, Cocaine Dependence, Diabetes Mellitus, Type 1, Epilepsy, Partial Seizures, Fragile X Syndrome, Healthy, Heart Failure, High Altitude Pulmonary Hypertension, Idiopathic Pulmonary Fibrosis, Kidney Disease, Methamphetamine Dependence, Mild Alzheimer's Disease

Studies at this site

• A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia — Completed
• An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia — Completed
• A Study of KRN23 in X-linked Hypophosphatemia — Completed
• A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• Phase I Rising-dose Study to Assess Tolerability, Safety, Pharmacokinetics, Pharmacodynamics of AR09 — Stopped early
• A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years — Completed
• A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes — Completed
• Variability in the Measurement of WBCT Between Blood Drawn From Indwelling Catheters and Direct Venipuncture — Completed
• A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model — Stopped early
• Antagonism of Opioid-Induced Respiratory Depression by CX1739 With Preservation of Opioid Analgesia — Status unconfirmed
• A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure — Completed
• PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND) — Completed
• The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers — Completed
• Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial Pressure — Completed
• Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome — Completed
• Effects of TT301 on Cytokine Levels Post Endotoxin Challenge — Completed
• Effect of Orlistat in Body Composition — Completed
• Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease — Stopped early
• Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction — Completed